+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-alcoholic Steatohepatitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology

  • PDF Icon

    Report

  • 104 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5598855
Description Jump to:

Quick Summary:

In a landscape where the pharmaceutical industry continually evolves, staying informed on the latest market developments is crucial for strategic decision-making. Our comprehensive report on the Non-alcoholic Steatohepatitis (NASH) Drug market provides an in-depth analysis that senior executives need to remain competitive and to identify emerging opportunities in a field marked by innovation and regulatory changes.

Covering an extensive range of geographical regions, from North America to the MEA, our research offers a granular view of supply and demand dynamics, key player positioning, and strategic market shifts. With detailed profiles on global leaders such as AstraZeneca PLC and Gilead Sciences, along with insights on smaller contenders, this report equips you with the intelligence to carve out a superior competitive strategy in the complex NASH drug market landscape.

This report describes the global market size of Non-alcoholic Steatohepatitis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Non-alcoholic Steatohepatitis Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Companies Covered

  • AstraZeneca PLC
  • Eli Lilly
  • Gilead Sciences
  • Merck & Co. Inc.
  • Novo Nordisk
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Enanta Pharmaceuticals Inc.
  • Ionis Pharmceuticals Inc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Non-Alcoholic Steatohepatitis Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in North America (2019-2029)
8.1 Non-Alcoholic Steatohepatitis Drug Market Size
8.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in South America (2019-2029)
9.1 Non-Alcoholic Steatohepatitis Drug Market Size
9.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in Asia & Pacific (2019-2029)
10.1 Non-Alcoholic Steatohepatitis Drug Market Size
10.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in Europe (2019-2029)
11.1 Non-Alcoholic Steatohepatitis Drug Market Size
11.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Non-Alcoholic Steatohepatitis Drug Market in MEA (2019-2029)
12.1 Non-Alcoholic Steatohepatitis Drug Market Size
12.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Non-Alcoholic Steatohepatitis Drug Market (2019-2024)
13.1 Non-Alcoholic Steatohepatitis Drug Market Size
13.2 Non-Alcoholic Steatohepatitis Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Non-Alcoholic Steatohepatitis Drug Market Size by Type
Chapter 14 Global Non-Alcoholic Steatohepatitis Drug Market Forecast (2024-2029)
14.1 Non-Alcoholic Steatohepatitis Drug Market Size Forecast
14.2 Non-Alcoholic Steatohepatitis Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Non-Alcoholic Steatohepatitis Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca PLC
15.1.1 Company Profile
15.1.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.1.3 SWOT Analysis of AstraZeneca PLC
215.1.4 AstraZeneca PLC Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.2.3 SWOT Analysis of Eli Lilly
215.2.4 Eli Lilly Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Gilead Sciences
15.3.1 Company Profile
15.3.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.3.3 SWOT Analysis of Gilead Sciences
215.3.4 Gilead Sciences Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Merck & Co. Inc.
15.4.1 Company Profile
15.4.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.4.3 SWOT Analysis of Merck & Co. Inc.
215.4.4 Merck & Co. Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Novo Nordisk
15.5.1 Company Profile
15.5.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.5.3 SWOT Analysis of Novo Nordisk
215.5.4 Novo Nordisk Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Novartis AG
15.6.1 Company Profile
15.6.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.6.3 SWOT Analysis of Novartis AG
215.6.4 Novartis AG Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Pfizer Inc.
15.7.1 Company Profile
15.7.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.7.3 SWOT Analysis of Pfizer Inc.
215.7.4 Pfizer Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Roche Holding AG
15.8.1 Company Profile
15.8.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.8.3 SWOT Analysis of Roche Holding AG
215.8.4 Roche Holding AG Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Enanta Pharmaceuticals Inc.
15.9.1 Company Profile
15.9.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.9.3 SWOT Analysis of Enanta Pharmaceuticals Inc.
215.9.4 Enanta Pharmaceuticals Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
15.10 Ionis Pharmceuticals Inc.
15.10.1 Company Profile
15.10.2 Main Business and Non-alcoholic Steatohepatitis Drug Information
15.10.3 SWOT Analysis of Ionis Pharmceuticals Inc.
215.10.4 Ionis Pharmceuticals Inc. Non-alcoholic Steatohepatitis Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Non-Alcoholic Steatohepatitis Drug Report
Table Data Sources of Non-Alcoholic Steatohepatitis Drug Report
Table Major Assumptions of Non-Alcoholic Steatohepatitis Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Non-Alcoholic Steatohepatitis Drug Picture
Table Non-Alcoholic Steatohepatitis Drug Classification
Table Non-Alcoholic Steatohepatitis Drug Applications
Table Drivers of Non-Alcoholic Steatohepatitis Drug Market
Table Restraints of Non-Alcoholic Steatohepatitis Drug Market
Table Opportunities of Non-Alcoholic Steatohepatitis Drug Market
Table Threats of Non-Alcoholic Steatohepatitis Drug Market
Table COVID-19 Impact For Non-Alcoholic Steatohepatitis Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Non-Alcoholic Steatohepatitis Drug
Table Cost Structure Analysis of Non-Alcoholic Steatohepatitis Drug
Table Key End Users
Table Latest News of Non-Alcoholic Steatohepatitis Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Non-Alcoholic Steatohepatitis Drug Market
Table Policy of Non-Alcoholic Steatohepatitis Drug Market
Table 2019-2029 North America Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2019-2029 North America Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2019-2029 North America Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 North America Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2019-2024 North America Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2019-2029 North America Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2029 United States Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Canada Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Mexico Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 South America Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2019-2029 South America Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2019-2029 South America Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 South America Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2019-2024 South America Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2019-2029 South America Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2029 Brazil Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Argentina Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Chile Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Peru Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2019-2029 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2029 China Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 India Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Japan Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 South Korea Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Southeast Asia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Australia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Europe Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2019-2029 Europe Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2019-2029 Europe Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 Europe Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2019-2024 Europe Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2019-2029 Europe Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2029 Germany Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 France Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 United Kingdom Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Italy Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Spain Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Belgium Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Netherlands Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Austria Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Poland Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Russia Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 MEA Non-Alcoholic Steatohepatitis Drug Market Size
Figure 2019-2029 MEA Non-Alcoholic Steatohepatitis Drug Market Size and CAGR
Table 2019-2029 MEA Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 MEA Non-Alcoholic Steatohepatitis Drug Key Players Revenue
Table 2019-2024 MEA Non-Alcoholic Steatohepatitis Drug Key Players Market Share
Table 2019-2029 MEA Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2029 Egypt Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Israel Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 South Africa Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2029 Turkey Non-Alcoholic Steatohepatitis Drug Market Size
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Size by Region
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Size Share by Region
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Share by Application
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Revenue
Figure 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Size and Growth Rate
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Market Share
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Market Share by Type
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Size by Region
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Size Share by Region
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Size by Application
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Share by Application
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Revenue
Figure 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Size and Growth Rate
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Key Vendors Market Share
Table 2024-2029 Global Non-Alcoholic Steatohepatitis Drug Market Size by Type
Table 2024-2029 Non-Alcoholic Steatohepatitis Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca PLC
  • Eli Lilly
  • Gilead Sciences
  • Merck & Co. Inc.
  • Novo Nordisk
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Enanta Pharmaceuticals Inc.
  • Ionis Pharmceuticals Inc.
  • NGM Biopharmaceuticals Inc.
  • Pliant Therapeutics
  • Inc.
  • Terns Pharmaceuticals Inc.
  • 89bio Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024 - Product Image

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Image

Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • 130 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024 - Product Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024

  • Clinical Trials
  • 240 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report - Product Image

Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2023-2028 - Product Image

Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2023-2028

  • Report
  • 142 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.